All Articles tagged MPS II

• Neurological Disorders
  August 29, 2022 EDT
  Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
  Karen S. YeeDavid AlexanderianYidie FengXiaowei RenBernd SchweikertOlulade Ayodele

  This study assessed the impact of timing of enzyme replacement therapy initiation and cognitive impairment status on the clinical characteristics and health resource utilization of patients with MPS II.

  Abstract
• Genetic Disorders
  May 12, 2022 EDT
  Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
  Olulade AyodeleKersten MüllerSolmaz SetayeshgarDavid AlexanderianKaren S. Yee

  The aims of this study were to assess the healthcare needs of patients with MPS II and to explore the impact of treatment on disease burden and healthcare resource utilization.

  Abstract